| pubmed-article:19338047 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19338047 | lifeskim:mentions | umls-concept:C0349639 | lld:lifeskim |
| pubmed-article:19338047 | lifeskim:mentions | umls-concept:C1515783 | lld:lifeskim |
| pubmed-article:19338047 | lifeskim:mentions | umls-concept:C0332466 | lld:lifeskim |
| pubmed-article:19338047 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19338047 | pubmed:dateCreated | 2009-5-4 | lld:pubmed |
| pubmed-article:19338047 | pubmed:abstractText | The t(7;11)(p15;p15) translocation has been reported as a rare and recurrent chromosomal abnormality in acute myeloid leukemia (AML) patients. The NUP98-HOXA9 fusion gene with t(7;11)(p15;p15) was identified and revealed to be essential for leukemogenesis and myeloproliferative disease. To date, t(7;11)(p15;p15) with NUP98-HOXA11 fusion has been reported only in one case of ph-negative chronic myeloid leukemia (CML). Here, we report a case of a 3-year-old girl with juvenile myelomonocytic leukemia (JMML) carrying t(7;11)(p15;p15) abnormality with NUP98-HOXA11 fusion. AML chemotherapy followed by bone marrow transplantation (BMT) was found to be effective in treating this disorder, and she remains in complete remission for 3 years after BMT. We suggest the possibility that AML chemotherapy might be effective for treating JMML with t(7;11)(p15;p15) abnormality and NUP98-HOXA11 fusion. | lld:pubmed |
| pubmed-article:19338047 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19338047 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19338047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338047 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19338047 | pubmed:month | May | lld:pubmed |
| pubmed-article:19338047 | pubmed:issn | 1096-8652 | lld:pubmed |
| pubmed-article:19338047 | pubmed:author | pubmed-author:HamamotoKazuk... | lld:pubmed |
| pubmed-article:19338047 | pubmed:author | pubmed-author:TakiTomohikoT | lld:pubmed |
| pubmed-article:19338047 | pubmed:author | pubmed-author:HayashiYasuhi... | lld:pubmed |
| pubmed-article:19338047 | pubmed:author | pubmed-author:FujitaNaotoN | lld:pubmed |
| pubmed-article:19338047 | pubmed:author | pubmed-author:MizoguchiYoko... | lld:pubmed |
| pubmed-article:19338047 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19338047 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:19338047 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19338047 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19338047 | pubmed:pagination | 295-7 | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:meshHeading | pubmed-meshheading:19338047... | lld:pubmed |
| pubmed-article:19338047 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19338047 | pubmed:articleTitle | Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion. | lld:pubmed |
| pubmed-article:19338047 | pubmed:affiliation | Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan. yoyotti129@yahoo.co.jp | lld:pubmed |
| pubmed-article:19338047 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19338047 | pubmed:publicationType | Case Reports | lld:pubmed |
